Advances in heart failure monitoring: Biosensors targeting molecular markers in peripheral bio-fluids
Tao Dong,Wangang Zhu,Zhaochu Yang,Nuno Miguel Matos Pires,Qijing Lin,Weixuan Jing,Libo Zhao,Xueyong Wei,Zhuangde Jiang
DOI: https://doi.org/10.1016/j.bios.2024.116090
IF: 12.545
2024-02-01
Biosensors and Bioelectronics
Abstract:Cardiovascular diseases (CVDs), especially chronic heart failure, threaten many patients’ lives worldwide. Because of its slow course and complex causes, its clinical screening, diagnosis, and prognosis are essential challenges. Clinical biomarkers and biosensor technologies can rapidly screen and diagnose. Multiple types of biomarkers are employed for screening purposes, precise diagnosis, and treatment follow-up. This article provides an up-to-date overview of the biomarkers associated with the six main heart failure etiology pathways. Plasma natriuretic peptides (BNP and NT-proBNP) and cardiac troponins (cTnT, cTnl) are still analyzed as gold-standard markers for heart failure. Other complementary biomarkers include growth differentiation factor 15 (GDF-15), circulating Galactose Lectin 3 (Gal-3), soluble interleukin (sST2), C-reactive protein (CRP), and tumor necrosis factor-alpha (TNF-α). For these biomarkers, the electrochemical biosensors have exhibited sufficient sensitivity, detection limit, and specificity. This review systematically summarizes the latest molecular biomarkers and sensors for heart failure, which will provide comprehensive and cutting-edge authoritative scientific information for biomedical and electronic-sensing researchers in the field of heart failure, as well as patients. In addition, our proposed future outlook may provide new research ideas for researchers.
biotechnology & applied microbiology,biophysics,chemistry, analytical,electrochemistry,nanoscience & nanotechnology